FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178510225> ?p ?o ?g. }

• W3178510225 endingPage "2845" @default.
• W3178510225 startingPage "2828" @default.
• W3178510225 abstract "Abstract Mutations in the STK11 (LKB1) gene regulate resistance to PD-1/PD-L1 blockade. This study evaluated this association in patients with nonsquamous non–small cell lung cancer (NSCLC) enrolled in three phase I/II trials. STK11 mutations were associated with resistance to the anti–PD-L1 antibody durvalumab (alone/with the anti-CTLA4 antibody tremelimumab) independently of KRAS mutational status, highlighting STK11 as a potential driver of resistance to checkpoint blockade. Retrospective assessments of tumor tissue, whole blood, and serum revealed a unique immune phenotype in patients with STK11 mutations, with increased expression of markers associated with neutrophils (i.e., CXCL2, IL6), Th17 contexture (i.e., IL17A), and immune checkpoints. Associated changes were observed in the periphery. Reduction of STAT3 in the tumor microenvironment using an antisense oligonucleotide reversed immunotherapy resistance in preclinical STK11 knockout models. These results suggest that STK11 mutations may hinder response to checkpoint blockade through mechanisms including suppressive myeloid cell biology, which could be reversed by STAT3-targeted therapy. Significance: Patients with nonsquamous STK11-mutant (STK11mut) NSCLC are less likely than STK11 wild-type (STK11wt) patients to respond to anti–PD-L1 ± anti-CTLA4 immunotherapies, and their tumors show increased expression of genes and cytokines that activate STAT3 signaling. Preclinically, STAT3 modulation reverses this resistance, suggesting STAT3-targeted agents as potential combination partners for immunotherapies in STK11mut NSCLC. This article is highlighted in the In This Issue feature, p. 2659" @default.
• W3178510225 created "2021-07-19" @default.
• W3178510225 creator A5001182619 @default.
• W3178510225 creator A5002836016 @default.
• W3178510225 creator A5004102706 @default.
• W3178510225 creator A5005019339 @default.
• W3178510225 creator A5007120197 @default.
• W3178510225 creator A5018139036 @default.
• W3178510225 creator A5019908292 @default.
• W3178510225 creator A5021503872 @default.
• W3178510225 creator A5022984824 @default.
• W3178510225 creator A5026826195 @default.
• W3178510225 creator A5028101098 @default.
• W3178510225 creator A5028518794 @default.
• W3178510225 creator A5031609759 @default.
• W3178510225 creator A5036485783 @default.
• W3178510225 creator A5043124797 @default.
• W3178510225 creator A5043949890 @default.
• W3178510225 creator A5045263771 @default.
• W3178510225 creator A5046158954 @default.
• W3178510225 creator A5055454866 @default.
• W3178510225 creator A5065218418 @default.
• W3178510225 creator A5065880126 @default.
• W3178510225 creator A5073775662 @default.
• W3178510225 creator A5080517610 @default.
• W3178510225 creator A5085976480 @default.
• W3178510225 creator A5087353638 @default.
• W3178510225 date "2021-07-06" @default.
• W3178510225 modified "2023-10-18" @default.
• W3178510225 title "Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown" @default.
• W3178510225 cites W1498931318 @default.
• W3178510225 cites W1873528488 @default.
• W3178510225 cites W1919712230 @default.
• W3178510225 cites W1987520066 @default.
• W3178510225 cites W2042386784 @default.
• W3178510225 cites W2044874695 @default.
• W3178510225 cites W2055284977 @default.
• W3178510225 cites W2064427517 @default.
• W3178510225 cites W2065260669 @default.
• W3178510225 cites W2129932872 @default.
• W3178510225 cites W2138319716 @default.
• W3178510225 cites W2145411470 @default.
• W3178510225 cites W2160390319 @default.
• W3178510225 cites W2171524684 @default.
• W3178510225 cites W2260067559 @default.
• W3178510225 cites W2273119405 @default.
• W3178510225 cites W2342358015 @default.
• W3178510225 cites W2529254901 @default.
• W3178510225 cites W2568946517 @default.
• W3178510225 cites W2574482078 @default.
• W3178510225 cites W2742440809 @default.
• W3178510225 cites W2742802588 @default.
• W3178510225 cites W2783142245 @default.
• W3178510225 cites W2791290180 @default.
• W3178510225 cites W2797855256 @default.
• W3178510225 cites W2799476413 @default.
• W3178510225 cites W2801456259 @default.
• W3178510225 cites W2801571624 @default.
• W3178510225 cites W2803397860 @default.
• W3178510225 cites W2804812017 @default.
• W3178510225 cites W2809153936 @default.
• W3178510225 cites W2891114718 @default.
• W3178510225 cites W2895058922 @default.
• W3178510225 cites W2902968854 @default.
• W3178510225 cites W2910958141 @default.
• W3178510225 cites W2947248753 @default.
• W3178510225 cites W2947923969 @default.
• W3178510225 cites W2952953974 @default.
• W3178510225 cites W2987764106 @default.
• W3178510225 cites W3041582595 @default.
• W3178510225 cites W3087058849 @default.
• W3178510225 doi "https://doi.org/10.1158/2159-8290.cd-20-1543" @default.
• W3178510225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34230008" @default.
• W3178510225 hasPublicationYear "2021" @default.
• W3178510225 type Work @default.
• W3178510225 sameAs 3178510225 @default.
• W3178510225 citedByCount "42" @default.
• W3178510225 countsByYear W31785102252021 @default.
• W3178510225 countsByYear W31785102252022 @default.
• W3178510225 countsByYear W31785102252023 @default.
• W3178510225 crossrefType "journal-article" @default.
• W3178510225 hasAuthorship W3178510225A5001182619 @default.
• W3178510225 hasAuthorship W3178510225A5002836016 @default.
• W3178510225 hasAuthorship W3178510225A5004102706 @default.
• W3178510225 hasAuthorship W3178510225A5005019339 @default.
• W3178510225 hasAuthorship W3178510225A5007120197 @default.
• W3178510225 hasAuthorship W3178510225A5018139036 @default.
• W3178510225 hasAuthorship W3178510225A5019908292 @default.
• W3178510225 hasAuthorship W3178510225A5021503872 @default.
• W3178510225 hasAuthorship W3178510225A5022984824 @default.
• W3178510225 hasAuthorship W3178510225A5026826195 @default.
• W3178510225 hasAuthorship W3178510225A5028101098 @default.
• W3178510225 hasAuthorship W3178510225A5028518794 @default.
• W3178510225 hasAuthorship W3178510225A5031609759 @default.
• W3178510225 hasAuthorship W3178510225A5036485783 @default.
• W3178510225 hasAuthorship W3178510225A5043124797 @default.
• W3178510225 hasAuthorship W3178510225A5043949890 @default.
• W3178510225 hasAuthorship W3178510225A5045263771 @default.

• next